Part 7/10:
Despite the positive discussion around psychedelics, concerns were raised regarding their use, particularly in individuals susceptible to psychosis or schizophrenia. Dr. Marks noted that the only individuals currently eligible for psychedelic treatments, particularly in clinical settings, are those with diagnoses of depression and PTSD, ensuring a controlled and supportive environment.
She highlighted the importance of therapy-assisted treatment, emphasizing that psychedelics should not be self-administered but taken in conjunction with professional support, ensuring better outcomes and safety throughout the process.